Cited by 246Complement system in diseasesRetinal Diseases and TreatmentsBiomarkers in Disease Mechanisms

Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein

Open access
Laine, Matti, Jarva, Hanna, Seitsonen, Sanna, Haapasalo, Karita, Lehtinen, Markus J, Lindeman, Nina, Anderson, Don H, Johnson, Patrick T +5 more·2007·The Journal of Immunology

Abstract

Complement factor H (FH) is an important regulator of the alternative complement pathway. The Y402H polymorphism within the seventh short consensus repeat of FH was recently shown to be associated with age-related macular degeneration, the most common cause of irreversible blindness in the Western world. We examined the effects of this polymorphism on various FH functions. FH purified from sera of age-related macular degeneration patients homozygous for the FH402H variant showed a significantly reduced binding to C-reactive protein (CRP), an acute phase protein, as compared with FH derived from unaffected controls homozygous for the FH402Y variant. Strongly reduced binding to CRP was also observed with a recombinant fragment of FH (short consensus repeat 5–7) containing the same amino acid change. Because the interaction of CRP and FH promotes complement-mediated clearance of cellular debris in a noninflammatory fashion, we propose that the reduced binding of FH402H to CRP could lead to an impaired targeting of FH to cellular debris and a reduction in debris clearance and enhanced inflammation along the macular retinal pigmented epithelium-choroid interface in individuals with age-related macular degeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.178.6.3831

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The risk-conferring Y402H CFH variant reduces binding affinity to C-reactive protein compared with the Y402Y variant.

    “The risk-conferring Y402H CFH variant (genotype CC) has also been reported to reduce the binding affinity to C-reactive protein (CRP), a pro-inflammatory molecule, as compared with the Y402Y variant (genotype TT).”

    From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Laine et al., 2007

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Laine, M., Jarva, H., Seitsonen, S., Haapasalo, K., Lehtinen, M. J., Lindeman, N., Anderson, D. H., Johnson, P. T., Järvelä, I., Jokiranta, T. S., Hageman, G. S., Immonen, I., & Meri, S.
Affiliations
  • University of Helsinki (FI)
  • University of California, Santa Barbara (US)
  • Department of Medical Genetics, University of Helsinki , Helsinki ,
  • University of Iowa (US)
Venue
The Journal of Immunology
Published
2007-03
Volume
178
Issue
6
Pages
3831-3836
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2151652430
Cited by
246
References
37
Citations by year
2026: 5 · 2025: 8 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 6 · 2016: 13 · 2015: 10 · 2014: 14 · 2013: 20 · 2012: 17
FWCI
10.28
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Helsingin ja Uudenmaan Sairaanhoitopiiri
  • Kidneeds
  • Ögonfonden
  • Academy of Finland
  • Silmä- ja kudospankkisäätiö
  • National Institutes of Health
  • National Eye Institute (EY11515, R01EY011515, R24EY017404)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
Keywords
complement factor H, C-reactive protein, alternative complement pathway, age-related macular degeneration, short consensus repeats, protein-protein binding affinity, inflammation, retinal pigment epithelium, choroid
MeSH terms
Aged, Aged, 80 and over, C-Reactive Protein, Female, Homozygote, Humans, Inflammation, Macular Degeneration, Male, Middle Aged, Pigment Epithelium of Eye, Polymorphism, Genetic, Protein Binding, Retina, Complement Factor H

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review